Location History:
- Sharon, PA (US) (1997 - 2001)
- Hermitage, PA (US) (1997 - 2021)
Company Filing History:
18 out of 31 
2 out of 2 
1 out of 1 
Years Active: 1997-2021
Title: Innovations and Contributions of Mitchell S Felder
Introduction
Mitchell S Felder, based in Hermitage, Pennsylvania, is a highly accomplished inventor recognized for his significant contributions to the field of medical treatments. With a remarkable portfolio of 23 patents, Felder's work revolves around innovative methods for treating complex medical conditions.
Latest Patents
Among his latest patents, Felder has developed a groundbreaking treatment method for Cockayne Syndrome (CS). This invention involves the extracorporeal treatment of a patient's body fluid, wherein blood is removed from a CS patient and targeted antibodies are applied. The targeted components—including mammalian target of rapamycin (mTOR) antigen or death-associated protein 1 (DAP1)—create an antibody-antigen complex, which is subsequently purified and returned to the patient. This method aims to enhance the quality of treatment for patients suffering from this rare genetic disorder.
Additionally, Felder has patented a method for the sequential extracorporeal treatment of bodily fluids. This versatile method can be applied to blood, cerebral spinal fluid, and lymph, involving a two-stage process. Initially, the bodily fluid undergoes a treatment, which may include medication, thermal treatment, or irradiation. In the second stage, the treatment components are efficiently removed before the purified fluid is returned to the patient. The system is designed for continuous processes, akin to dialysis, enhancing patient safety and comfort.
Career Highlights
Felder's career has been marked by his association with innovative companies, including Infectech, Inc. and Marv Enterprises, LLC. His work in these organizations has been pivotal in translating his patents into viable treatments that can significantly impact patient care.
Collaborations
Throughout his journey as an inventor, Felder has collaborated with notable colleagues, such as Robert-A Ollar and Robert A Ollar. These partnerships have fostered a collaborative environment conducive to innovation, underscoring the importance of teamwork in advancing healthcare technologies.
Conclusion
Mitchell S Felder's impressive portfolio of patents emphasizes his dedication to medical innovation and patient improvement. His contributions, particularly in the treatment of complex conditions like Cockayne Syndrome, highlight the valuable intersection of research and practical applications in healthcare. As he continues to push the boundaries of medical treatments, Felder remains a significant figure in the world of inventors, paving the way for future advancements.